Immune thrombocytopenia is a rare autoimmune disorder, affecting both children and adults. The global incidence of ITP is estimated at around 2–5 cases per 100,000 people annually, with prevalence higher in adults and a slight female predominance.
In 2024, the total cases of immune thrombocytopenia were approximately 186K cases in the leading markets (the US, EU4, the UK, and Japan), as per DelveInsight. Females comprised 63% of the total patient cohort, while males made up 37%. ITP is more common among children than adults. These numbers are further expected to grow due to improved disease awareness, better diagnostic techniques, and expanded access to healthcare....
